Wegovy And Zepbound Doses Available Again After Months Of Shortages, FDA Says—But Supplies Are Still Limited

Novo and Lilly have struggled to keep up with demand for semaglutide and tirzepatide—generic names for Ozempic, Wegovy, Mounjaro and Zepbound—and there have been reports people with diabetes have struggled to access the drugs as more people use them to lose weight.